Atlas Trials

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00445484 · COMPLETED

Trial details

NCT number
NCT00445484
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2007-01-01
Primary completion
2009-04-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.